PMC:7076992 / 5602-5685
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T17 | 43-49 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T37 | 43-49 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T38 | 80-82 | http://purl.obolibrary.org/obo/CLO_0007874 | denotes | MS |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T19 | 80-82 | Chemical | denotes | MS | http://purl.obolibrary.org/obo/CHEBI_73613 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T46 | 0-83 | Sentence | denotes | AC highlighted the potential use of immune plasma for treatment and drafted the MS. |